tiprankstipranks
Advertisement

XEML - ETF AI Analysis

Compare

Top Page

XEML

Xtrackers Europe Market Leaders ETF (XEML)

Rating:68Neutral
Price Target:
XEML, the Xtrackers Europe Market Leaders ETF, has a solid overall rating driven mainly by high-quality European blue chips with strong financial performance. Standout holdings like ABB, Richemont, Sanofi, and Roche contribute positively thanks to robust revenue growth, profitability, and strategic positioning in areas like luxury goods and pharmaceuticals. The rating is held back somewhat by names such as Schneider Electric, Safran, and SAP, where bearish or neutral technical trends and relatively high valuations introduce risk, and the fund is also notably concentrated in large European industrial and consumer names, which can increase exposure to regional and sector-specific downturns.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains so far this year and over the last three months, indicating positive recent momentum.
Strong Leading Companies in Top Holdings
Several of the largest positions, such as Safran, Schneider Electric, ABB, Novartis, and ASML, have delivered strong performance, helping drive the fund’s returns.
Broad European Country Exposure
Holdings spread across major European markets like France, the UK, Switzerland, Germany, Sweden, and others help reduce the impact of weakness in any single country.
Negative Factors
High Country Concentration in France
A large share of the portfolio is invested in French companies, which increases the fund’s sensitivity to economic or political issues in France.
Sector Concentration in General and Health Care
Most of the assets are in the broad “General” category and health care, meaning the fund may be less balanced if other sectors outperform.
Mixed Performance Among Top Holdings
Some major positions like Nestlé and Roche have shown weak or negative performance this year, which can drag on overall returns if the trend continues.

XEML vs. SPDR S&P 500 ETF (SPY)

XEML Summary

Xtrackers Europe Market Leaders ETF (XEML) follows the STOXX Europe Total Market Leaders Index, which focuses on 40 of the largest and strongest companies in Europe. It holds well-known names like Nestlé and ASML, giving you exposure to major European businesses across several countries and sectors. An investor might consider this ETF to diversify beyond their home market and tap into the long-term growth and stability of leading European companies in a single, simple investment. A key risk is that the value can rise and fall with the European stock market, so it is not guaranteed to make money.
How much will it cost me?The Xtrackers Europe Market Leaders ETF (XEML) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a niche index of Europe's top 40 companies, requiring specialized tracking.
What would affect this ETF?The XEML ETF, focused on Europe's leading companies, could benefit from positive economic growth in developed Europe, increased consumer spending, and advancements in healthcare and technology sectors, which are heavily represented in its holdings. However, it may face challenges from rising interest rates, regulatory changes in Europe, or economic slowdowns that could impact industrial and consumer-focused companies. Global geopolitical tensions or trade disruptions could also negatively affect its performance.

XEML Top 10 Holdings

XEML leans heavily into Europe’s corporate champions, with Dutch chip-equipment giant ASML and Swiss industrial player ABB doing much of the heavy lifting as their shares keep rising and set the tone for the fund. French names like Schneider Electric and L’Oréal are adding steady, if unspectacular, support. On the flip side, software heavyweight SAP has been losing steam, while Sanofi and Safran show more mixed signals, occasionally tugging on returns. Overall, this is a developed Europe story, concentrated in market leaders rather than any single niche sector.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
SAFRAN SA5.16%$268.04K€137.33B27.22%
67
Neutral
5.06%$263.28K
Nestlé SA4.60%$239.21KCHF202.64B-1.44%
71
Outperform
Compagnie Financiere Richemont SA4.56%$236.91KCHF107.76B23.72%
78
Outperform
Novartis AG4.55%$236.75KCHF215.97B26.50%
80
Outperform
Roche Holding AG4.54%$236.19K$315.55B23.56%
73
Outperform
ABB Ltd4.52%$235.25Kkr1.86T87.78%
78
Outperform
Schneider Electric4.50%$233.94K€162.91B36.13%
62
Neutral
GlaxoSmithKline4.45%$231.15K£77.17B37.17%
77
Outperform
Vinci SA4.44%$230.60K€72.84B6.12%
76
Outperform

XEML Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
25.23
Positive
100DMA
25.21
Positive
200DMA
Market Momentum
MACD
0.16
Negative
RSI
59.82
Neutral
STOCH
69.21
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XEML, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 25.57, equal to the 50-day MA of 25.23, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.16 indicates Negative momentum. The RSI at 59.82 is Neutral, neither overbought nor oversold. The STOCH value of 69.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XEML.

XEML Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$5.10M0.35%
68
Neutral
$74.62M0.45%
60
Neutral
$70.66M0.09%
63
Neutral
$67.22M0.58%
65
Neutral
$36.49M0.65%
62
Neutral
$5.15M0.70%
55
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
XEML
Xtrackers Europe Market Leaders ETF
26.07
1.27
5.12%
DBEZ
Xtrackers MSCI Eurozone Hedged Equity ETF
FLEU
Franklin FTSE Eurozone ETF
EUDG
WisdomTree Europe Quality Dividend Growth Fund
PTEU
Pacer Trendpilot European Index ETF
FPXE
First Trust IPOX Europe Equity Opportunities ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement